Quantcast

Latest Clinical research Stories

2014-06-17 08:30:10

MOMENCE, Ill., June 17, 2014 /PRNewswire/ -- FutureCeuticals, Inc. today announced publication of the results of another successful human clinical study on FruiteX-B® calcium fructoborate, a patented plant mineral complex. The double-blind, placebo-controlled study examined the effects of FruiteX-B® supplementation during fourteen days on subjects with self-reported knee discomfort. The study population was equally divided between generally healthy men and women ranging in ages...

2014-06-17 08:28:44

SEATTLE, June 17, 2014 /PRNewswire/ -- CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into a Master Services Agreement for process validation activities and clinical manufacturing of another of MacroGenics'...

2014-06-17 08:28:28

Previously released interim results from the trial showed positive safety and efficacy; 300 patients with moderate to severe disease were enrolled in the study PETACH TIKVA, Israel, June 17, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has finalized enrollment in its Phase II/III trial of CF101 for the treatment...

2014-06-16 23:12:21

On June 13, the FDA notified of a recall (Class I) of Smiths Medical Portex Low Dead Space Connector with Sideport, 3.5mm because one lot was mislabeled. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 16, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Portex Low Dead Space Connector. The FDA...

2014-06-16 23:06:45

DIARYpro® Available on Patients’ Smartphones – Delivering Reliability while Reducing Trial Costs Philadelphia (PRWEB) June 16, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced an expansion to its comprehensive suite of electronic Clinical Outcome Assessment (eCOA) data collection solutions for use in clinical trials. With this expansion, clinical trial sponsors can improve trial efficiencies while...

2014-06-16 23:06:37

MasteScope® 2.0 Simplifies Complex Clinical Trials, Enabling Investigative Sites to Focus on Patients and Data Quality PHILADELPHIA – June 17, 2014 (PRWEB) June 16, 2014 -- ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced the availability of MasterScope® 2.0, a new, comprehensive platform for spirometry, ECG, and home monitoring. Especially designed for standardized and centralized clinical trials,...

2014-06-16 23:04:26

Transparency Market Research published a new report "Clinical Trial Management System Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html. Albany, New York (PRWEB) June 16, 2014 According to a new market report published by Transparency Market Research "Clinical Trial Management System Market- Global...

2014-06-16 23:01:01

The firm currently represents patients who allege that they have suffered serious side effects from use of Xarelto. Rockville Centre, NY (PRWEB) June 16, 2014 The Rottenstein Law Group, a national personal injury law firm with over 25 years of experience helping plaintiffs who have been injured by dangerous prescription drugs and defective medical devices, announces the launch of an information center on Xarelto® Lawsuits on its website, to assist individuals who might be considering...

2014-06-16 16:25:30

Company to participate in showcase at 2014 BIO International Convention GREENVILLE, S.C., June 16, 2014 /PRNewswire/ -- KIYATEC, a private company prioritizing the accurate ex vivo prediction of patients' response to drug treatment, is one of seventeen companies that has been selected to participate in the 2014 BIO International Convention's newly created Innovation Zone in San Diego, California from June 23(rd) thru the 26(th). The Innovation Zone is a result of a partnership...

2014-06-16 12:29:31

Latest RTSM technology features standardized study components for faster implementation and greater design flexibility BOSTON, June 16, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the launch of a new version of its industry standard ClinPhone(®) RTSM services designed to help clients start clinical trials more quickly. The leading edge randomization and trial supply management (RTSM) solution...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related